TherapeuticsMD extends loan maturity to July 29, 2022; evaluating Chapter 11 protection

TherapeuticsMD, Inc.

Maturity date of Financing Agreement amended to July 29, 2022, a one-day extension from the amendment date.
Company's board evaluating all options for capital structure, including refinancing and potential Chapter 11 filing.
Company states it intends to maintain normal operations during evaluation.
Amendment indicates near-term liquidity stress and risk of bankruptcy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.